Figure 7.
Figure 7. Mechanisms of resistance to EZH2 inhibitors. The model shows the mechanism by which IGF-1R, PI3K and MAPK, or EZH2 mutations confer resistance to EZH2 inhibitors in DLBCL cells.

Mechanisms of resistance to EZH2 inhibitors. The model shows the mechanism by which IGF-1R, PI3K and MAPK, or EZH2 mutations confer resistance to EZH2 inhibitors in DLBCL cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal